Maurizio Burattini

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +17

Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · Clinical Lymphoma Myeloma & Leukemia · 2012 · 43 citations

Medicine, Biostatistics, Oncology +11

Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function

Claudio Coletta, Alfonso Galati, Gabriella Greco et al. · Journal of the American College of Cardiology · 1995 · 37 citations

Medicine, Cardiology, Clinical Cardiology +12

Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study

Mirko Di Rosa, Jacopo Sabbatinelli, Luca Soraci et al. · Journal of Translational Medicine · 2023 · 33 citations · Full text

Medicine, Geriatric Medicine, Hematology +13

Thalidomide‐dexamethasone <i>versus</i> Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · British Journal of Haematology · 2008 · 28 citations

Medicine, Hematology, Oncology +13